Contact information
https://orcid.org/0000-0003-1322-2027
Botnar Institute for Musculoskeletal Sciences, Old Rd, Headington, Oxford OX3 7LD
she/her
Research groups
Loren Kell
DPhil (Oxon), BSc (Hons)
Postdoctoral Researcher in Translational Immunology
I am a postdoctoral researcher in the Translational Pharmacology (Fullerton) Group at the Botnar Institute. I am mainly interested in understanding differences in human immunity based on sex and biological ageing. Following my undergraduate degree at University College London, I obtained my DPhil/PhD from Oriel College, Oxford, where I worked on describing the geroprotective effects of mTOR inhibitors on immune DNA damage with Ghada Alsaleh, Lynne Cox, and Katja Simon. In my current role, I am leveraging human immune challenge models using the KLH neoantigen to explore the generation of resident memory T cells.
Key publications
Rapamycin exerts its geroprotective effects in the ageing human immune system by enhancing resilience against DNA damage
Preprint
Kell L. et al, (2025)
B0124 DIMETHYL FUMARATE MODULATES T CELL METABOLISM AND FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENT SAMPLES
Conference paper
Kell L. et al, (2023), Annals of the Rheumatic Diseases, 82, 1241 - 1241
Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab?
Journal article
Reddy VR. et al, (2022), Rheumatology (Oxford), 61, 2894 - 2904
Mutational and phenotypic characterization of hereditary hemorrhagic telangiectasia.
Journal article
Shovlin CL. et al, (2020), Blood, 136, 1907 - 1918